La maquina de compounding de Buffett, ahora en transicion post-fundador.
Precio de referencia BRK.B $511.21 · BRK.A $767,712 (2026-07-31) · análisis 2026-07-31
Resumen ejecutivo
Berkshire es la máquina de asignación de capital más exitosa de la historia moderna — 19% BVPS CAGR durante 60 años (1965-2023) bajo Warren Buffett + Charlie Munger, comparado con 10% del S&P 500 total return. En 2025 ocurrió la transición central del research: Greg Abel asumió como CEO, Warren queda como Chairman "en oficina 5 días/semana" en rol advisor. La primera annual letter bajo Abel (FY2025, publicada 2026) enfatiza continuidad cultural y disciplina de capital. Cash + Treasuries récord: $370B+ dry powder — la biggest cache en la historia de Berkshire, herencia deliberada de Buffett a Abel.
La tesis descansa en moat 15/21 en 7 Powers de Helmer — top tier con 3 powers en 3/3: Scale Economies (float $180B + cash $370B únicos), Cornered Resource (BNSF railway corridors + BHE utility franchises + GEICO direct-to-consumer), y Process Power (60 años de cultura descentralizada aplicada a 400,000 empleados). Insurance float durability (7.4% CAGR 2015-2025) + interest income $14-18B anuales del cash pile a 4-5% rates + Abel operator track record en BHE (15% CAGR 1999-2018 standalone) sostienen la compounding machine post-Buffett.
Valuación blended IV: ~$510/share BRK.B (rango $450-$600), precio actual $511.21 → MoS 0-8%. BRK.B cotiza en percentile 90+ de su rango histórico propio de P/BV (1.71x actual vs mediana 1.35x) — near all-time high. Los tres lentes convergen: P/BV mean-reversion sugiere $405, DCF prob-weighted $533, Sum-of-parts $564. Precio de compra agresivo post-premortem: $325-345 (30-35% MoS). Este level requeriría corrección de mercado o crisis-atipico — no probable corto plazo.
El swing factor dominante próximos 3-5 años es el post-Buffett multiple compression. Aun con Abel ejecutando bien y BVPS creciendo 8% CAGR, si el múltiple contract de 1.7x a 1.3x P/BV, TSR es -20% a -30% cumulativo. La compensación del research: Abel es genuino operator (no placeholder) + cash pile es asset material (no dead weight) + insurance economics + cultural moat 15/21 sobreviven la transition. Question: el mercado ya está pricing esto?
El negocio
Modelo de negocio identificado: Insurance-first diversified holding company + capital allocation platform. Modelo único — no encaja en taxonomía GICS estándar.
Cómo genera revenue. Berkshire opera 3 capas económicas:
- Insurance & Other operations (~55% revenue, $205B FY24): GEICO ($43B), BHRG reinsurance ($22B), BH Primary ($14B), plus Manufacturing/Service/Retail (~$125B) — 60+ operating businesses (Precision Castparts, Marmon, Lubrizol, See's Candies, NetJets, McLane, Duracell, etc.).
- BNSF Railway (~7%, $24B): Class I railroad, essential-service, monopolistic corridors. ~$5B op income (21% margin).
- Berkshire Hathaway Energy - BHE (~7%, $25B): Regulated utilities + pipelines. PacifiCorp, MidAmerican, Nevada, Northern Powergrid UK. Op margin 15%.
Unit economics — el motor real: - Insurance float: ~$180B (2025), grew from $88B en 2015 = CAGR 7.4%. Es capital pagado a Berkshire por sostenerlo cuando underwriting es profitable - Cost-of-float: históricamente near-zero o negative (underwriting profitable en la mayoría de los años) - Cash + Treasuries: >$370B — récord histórico. Genera $14-18B annual interest income at 4-5% rates - Buyback economics: counter-cíclico. 2020-2022 agresivo ($25B/año at P/BV 1.2-1.3x); 2024-2025 modesto ($3-4B con stock en highs)
Berkshire's economic engine (formulaic):
IV growth = (Float × Investment yield) × Insurance leverage
+ (Operating businesses earnings × ROIC × Reinvestment)
+ (M&A alpha × Cash deployment rate)
Escala actual (FY2025): - Total revenue: ~$380B - Operating earnings: ~$40B - BVPS BRK.A: ~$450K/share (BRK.B equivalente ~$300) - Insurance float: ~$180B - Cash + Treasuries: >$370B - Empleados: ~400,000 (según Abel FY2025 letter)
Fase del ciclo: mature compounder machine post-Buffett transition. Warren era exceptional 60y (19% CAGR); Abel era baseline expected 6-9% CAGR at scale.
Contexto de industria
Berkshire es único — no encaja limpio en ninguna categoría GICS. Analizo 3 lentes convergentes:
Sub-industria #1 · P/C Insurance Holdings: - Global TAM: $2.5-3T annual gross premiums - US market share Berkshire (GEICO + primary): ~8-9% (top 3 auto insurance) - Reinsurance global rank: top 5 (BHRG + Gen Re) - HHI ~800-1000 (fragmented); Berkshire dominant en float scale - Float dynamic: $170-180B (unique) × 4-5% investment yield = $7-9B "free" annual income
Sub-industria #2 · Diversified Conglomerates: - Historical "conglomerate discount" of 15-30% typical (ITT, Textron, Litton legacy) - Berkshire históricamente escaped discount: sold P/B 1.3-1.5x premium during Buffett era - Post-Buffett question: ¿mantiene el premium o converge a peer discount?
"Industry" #3 · Capital Allocation: - Berkshire's real "industry" es capital allocation - Inputs: float ($180B), operating CF ($40-50B/año), cash pile ($370B) - Buffett-era track record: BVPS CAGR outperformed S&P 500 total return por ~5pp per annum over 60y
Forward CAGR projection (Berkshire aggregate):
| Horizonte | Estimated BVPS CAGR | Reasoning |
|---|---|---|
| 3y (2026-2029) | 8-10% | Abel deploy phase + insurance hard cycle tail + interest income on cash pile |
| 5y (2026-2031) | 7-9% | Normalization to secular Berkshire baseline; post-Buffett multiple discount possible |
| 10y (2026-2036) | 6-8% | Structural mid-single-digit as size drag + market efficiency compound |
Tailwinds + headwinds matrix:
| Force | Type | Prob | Impact |
|---|---|---|---|
| P/C insurance hard market tail | Tailwind | Alta | +200-400bp op earnings 2026-2027 |
| Rail intermodal recovery | Tailwind | Alta | +100-200bp BNSF |
| BHE rate base +6% CAGR | Tailwind | Alta | +50-100bp op earnings |
| Interest income $370B × 4-5% | Tailwind | Alta actual | $14-18B annual float income |
| Post-Buffett multiple compression | Headwind | Media-Alta | -10 a -20% P/BV |
| M&A execution risk under Abel | Headwind | Media | Case-by-case |
| BHE wildfire liability (PacifiCorp) | Headwind | Media | -$5 a -$15B contingent |
| P/C soft market cycle 2027-2028 | Headwind | Media-Alta | -200-400bp op earnings insurance |
| Interest rate collapse <2% | Headwind | Baja | -$8-12B float income |
Regulatory landscape: - P/C insurance: state-level (50 DOI) — regulatory risk contained - Rail: STB (federal) — 2024-2025 sustained scrutiny post-Ohio derailment - Utility BHE: FERC + state PUCs + PacifiCorp wildfire litigation ongoing - Trump admin (2025-2028): utility-favorable, antitrust permissive → BNSF strategic optionality
Moat, KPIs y management
Moat — Hamilton Helmer's 7 Powers (15/21 · top tier)
| Power | Score (0-3) | Comentario |
|---|---|---|
| Scale Economies | 3/3 | $1T market cap. Float $180B (unique). Cash pile $370B (unique). Regulatory + rating agency scale = dominant. |
| Cornered Resource | 3/3 | GEICO direct-to-consumer + BNSF corridors + BHE regulated franchises. Each quasi-monopolistic in category. |
| Process Power | 3/3 | Berkshire Business System (decentralized model + culture + capital allocation discipline). 60 años applied to 400+ acquisitions. |
| Switching Costs | 2/3 | Insurance customers switch (GEICO churn), but B2B counterparty (BNSF customers, BHE ratepayers) captive |
| Branding | 2/3 | "Berkshire" + "Buffett" massive equity/trust. Families sell to Berkshire because of trust. Post-Buffett needs preservation. |
| Network Effects | 1/3 | Some — bigger Berkshire = bigger reputation = better M&A funnel. Limited traditional network. |
| Counter-Positioning | 1/3 | Culture (no guidance, no dividends, long-term) is anti-Wall-Street but not obviously "counter-positioned" |
| TOTAL | 15/21 | Wide moat top-tier (comparable a NOW 18, COST 15, MSFT 14) |
Detalle de los 3 Powers máximos:
Scale Economies (3/3): Float $180B (no other US insurance holding has this — Chubb ~$40B, Progressive ~$30B). Cash pile $370B (>2x Apple's cash). Cost-of-capital near-zero on float. Structurally forever durability.
Cornered Resource (3/3): BNSF — US has only 4 Class I railroads west of Mississippi. Corridors irreplaceable. BHE PacifiCorp/MidAmerican — regulated utility franchises. GEICO — direct-to-consumer channel + brand + 60 años tech = defensible. Decades durability.
Process Power via Berkshire Culture (3/3): Decentralized subsidiary model + zero-based capital allocation + 60-year track record applied to 100+ acquisitions. Vulnerability: requires strong CEO with owner mindset. Abel signals "culture unchanged into perpetuity" in FY2025 letter. Currently secure but transition-tested.
KPIs Operacionales
KPI #1 — BVPS growth (Buffett's classical benchmark):
| Año | BVPS BRK.A ($000s) | YoY |
|---|---|---|
| 2015 | 155.5 | +6.4% |
| 2018 | 212.5 | +23% (tax reform) |
| 2020 | 285 | +9% |
| 2022 | 312 | -13% (mark-to-market) |
| 2024 | 410 | +4% |
| 2025 est | ~450 | +10% |
CAGR 2015-2025 ~10.7%. S&P 500 total return same period ~11-12% = Berkshire mid-cycle underperformed by ~1pp per year last decade.
KPI #2 — Insurance Float: 2015 $88B → 2025 ~$180B = 7.9% CAGR.
KPI #3 — Cash + Treasuries (dry powder): Doubled 2023 → 2025 ($168B → $370B+). Reflects Apple trim + T-bill yield + Buffett caution. Abel's inheritance.
KPI #4 — Operating Earnings: 2019 $23.8B → 2024 $38.5B → 2025 est $40B. CAGR 2019-2025 ~9%.
KPI #5 — Ratios de Valuación Históricos (P/BV):
| Percentil (10y) | P/BV |
|---|---|
| 5th | 1.10x |
| 25th | 1.25x |
| 50th (median) | 1.35x |
| 75th | 1.45x |
| 95th | 1.65x |
| Actual (2026-07-31) | 1.71x |
Actual P/BV en 1.71x = percentile 90+ del rango histórico propio — near all-time high. Post-COVID/rate normalization re-rated Berkshire higher; post-Buffett could reverse.
Capital Allocation Histórico
Berkshire es su capital allocation.
Major M&A (60y selected):
| Año | Deal | Precio | Grade |
|---|---|---|---|
| 1972 | See's Candies | $25M | A+ (10x return) |
| 2010 | BNSF Railway | $44B | A |
| 2015 | Precision Castparts | $37B | B (impaired $10B 2020) |
| 2016 | Duracell | $4.7B | B+ |
| 2022 | Alleghany | $12B | B+ (integrating) |
| 2025 | OxyChem | $12B | TBD (Abel-era) |
| 2025 | Bell Laboratories | small | TBD (Abel-era) |
Aggregate M&A grade Buffett era: A- overall. Some misses (Kraft Heinz), several wins (See's, BNSF, Duracell).
Buyback pattern: counter-cyclical. 2020-2022 aggressive at 1.2-1.3x P/BV ($25B/y). 2024-2025 modest ($3-4B) as stock hit highs. Signals Buffett/Abel view stock as fair-valued to slightly overvalued at current levels.
Management — The Great Transition
Warren E. Buffett (Chairman, 96 años en 2026): stepped down as CEO in 2025. Continues "en oficina 5 días/semana" as advisor. Shares to philanthropy over 10y post-passing.
Charles T. Munger: falleció noviembre 2023 (99 años). Legacy vice-chair role vacant.
Gregory E. Abel (CEO desde 2025): ex-BHE CEO 1999-2018 (compounded ~15% CAGR standalone). Vice-Chair Non-Insurance Operations 2018-2025. First annual letter as CEO published Feb 2026.
Ajit Jain (Vice-Chair Insurance, 74 años): runs GEICO + Gen Re + BHRG. Buffett called him "most valuable person for Berkshire."
Skin in the game: - Buffett: ~15% stake (~$150B) with philanthropic transfer plan - Munger family: ~1-2% - Combined founder/heir aggregate: ~17-18% of Berkshire — long-term aligned governance - Abel personal stake: ~$300M (small vs Buffett, material personally)
Abel FY2025 letter — key signals: 1. Culture continuity: "unchanged and will continue into perpetuity" 2. Fortress balance sheet: "$370B+ dry powder... an asset, not a risk" 3. Decentralized model: "will not change" 4. Capital discipline: "invest in businesses we thoroughly understand" 5. M&A pipeline signal: "confidentially shared with us... prompt response... no financing contingency"
Compensation: Abel + Jain modestos por S&P 500 standards ($16M range). Zero performance-based stock. Aligned via ownership + reputation, not comp.
Overall Management Grade: A- (Abel era beginning). Highest quality management in scaled US business. Only downside is inherent transition uncertainty — Abel is not Buffett + Munger 60y track record.
Riesgos
Ejercicio Munger — es julio 2031, BRK.B a $511 en julio 2026 compoundó <5% anual o perdió capital. ¿Qué pasó?
Top 10 Riesgos
| # | Riesgo | Prob | Sev | Early indicator |
|---|---|---|---|---|
| 🔴 1 | Post-Buffett multiple compression material — P/BV comprime de 1.7x a 1.2-1.3x sobre 3-5 años | 35-45% | -20 a -35% price ($340-410) | P/BV sostenidamente <1.5x; sell-side downgrades citing transition; Warren public appearances decrease |
| 🔴 2 | Insurance mega-catastrophe > $75B insured loss — pandemic / cyber / mega-hurricane | 15-25% en 5y | -15 a -25% | Named events >$30B early estimates; BHRG earnings volatility rising |
| 🟡 3 | BHE PacifiCorp wildfire liability escalates — California-parallel materializes | 25-35% | -8 a -15% | Adverse Oregon court rulings; PUC rate recovery denial |
| 🟡 4 | Rate collapse to <2% permanent — recession + fiscal dominance | 10-20% | -10 a -18% | Fed pivot <3% funds rate; 10y Treasury sustained <3% |
| 🟡 5 | Abel forces bad M&A deployment — cash pile pressure → overpay | 25-30% | -10 a -20% | M&A ≥$25B in 24m; multiple ≥1.5x book; post-close impairments |
| 🟡 6 | Culture erosion post-Buffett full-time exit — subsidiary CEO exodus | 15-25% en 5y | -10 a -25% multiple | Multiple senior subsidiary CEO exits; comp structure changes; board composition shifts |
| 🟠 8 | BNSF STB regulatory disruption — service metrics adverse rulings | 15-25% | -3 a -8% | STB rulings; BNSF service metrics deterioration |
| 🟠 9 | US corporate tax hike to 28% | 10-15% | -5 a -10% | 2028 election forecasts; congressional legislation |
| 🟢 10 | Antitrust action against conglomerate structure | <10% | -15 a -25% | FTC/DOJ statements on conglomerate structures |
Test de salida (post-premortem)
IV probabilidad-ponderado post-premortem ajusta de $510 a ~$475 cuando pondero los top-5 risks. MoS requerido sube de 25% a 30-35% given transition uncertainty.
Buy target ajustado real: $325-345 (30-35% MoS post-premortem, from $475 IV).
- Half position (1.5-3%): at $345-450
- Avoid/reduce: at $580+
Puntos ciegos declarados
- PacifiCorp exact wildfire liability range ($2-30B possible)
- Abel deployment style (first year, few data points)
- Warren's health timeline
- Insurance mega-cat probability (climate + cyber tail)
- OXY doubled?)
Anti-tesis · con la misma convicción
Overvaluation dressed como safe haven. P/BV 1.7x en 2026 = percentile 90+ del rango histórico propio. El "Buffett premium" incorporado en el precio es exactamente lo que se elimina post-transition — no hay razón matemática para que 1.7x P/BV sostenga cuando Warren no está en la oficina. Convergencia hacia peer set implica BRK.B a $380-410 range = 20-25% downside sin cambio operativo.
Cash pile deployment challenge. $370B es 34% del market cap. Buffett-era M&A track record de deploying cash está en decline — última major M&A grande (Precision Castparts 2015) fue impaired. Berkshire dejó de comprar Occidental en Q2 2026. Cash sitting at 4% Treasuries es "acceptable" pero no "IV-accretive." Aggregate ROIC compresses de 10% a 6-7% as cash proportion increases.
Concentration in aging businesses. MSR ($200B of SoP IV) es 60+ operating businesses many in mature/declining verticals. See's flat, NetJets aviation faces demographic drift, insurance is competitive. BNSF has secular headwinds from EV/renewable transition + industrial reshoring uncertain. BHE has PacifiCorp overhang. The "wonderful businesses" thesis is aging.
Variant perception — en qué pienso distinto al consenso
Consenso sell-side implícito: BRK.B target ~$525, "hold" majority post-2024 rerating. Descuenta transition ~5% pero espera Abel = Buffett-lite.
Yo variance en 3 puntos:
1. Multiple compression más agresivo que consenso. Sell-side descuenta ~5% post-transition. Yo veo 15-25% probabilidad de compression a 1.3x P/BV en 3-5 años. Diferencia: -$50-80 en IV weighted.
2. Cash pile es asset MATERIAL, not neutral. Sell-side trata $370B como "dead capital." Actualmente genera $14-18B annual = ~4% de mkt cap en earning power. Diferencia: +$30-50 upside en IV.
3. Abel operator credibility genuine. BHE 15% CAGR 1999-2018 es real. Sell-side asigna Abel Buffett-lite discount ~10%. Yo creo Abel puede outperform Buffett-era last-decade baseline si $370B se deploy en un correction. Diferencia: +$50-100 upside bull case.
Net variant perception: fair value estimate propio $450-540 (blended weighted center $510) vs consensus target ~$525 = broadly aligned central case pero MÁS conservador en Lens 1 tail risk + MÁS optimista en cash pile deployment optionality. El bull case ($650 DCF, +21%) probablemente descartado por sell-side = "hidden option" pricing en Abel-era Berkshire.
